M&A Deal Summary

ImmunoPrecise Acquires BioStrand

On March 29, 2022, ImmunoPrecise acquired internet software and services company BioStrand for 20M EUR

Acquisition Highlights
  • This is ImmunoPrecise’s 1st transaction in the Internet Software and Services sector.
  • This is ImmunoPrecise’s 0th largest (disclosed) transaction.
  • This is ImmunoPrecise’s 1st transaction in Belgium.

M&A Deal Summary
Date 2022-03-29
Target BioStrand
Sector Internet Software and Services
Buyer(s) ImmunoPrecise
Deal Type Add-on Acquisition
Deal Value 20M EUR

Target

BioStrand

Diepenbeek , Belgium
BioStrand is a provider of cloud-based solution to perform multi-omics research faster and more accurately, with more effective data analysis. BioStrand is based in Diepenbeek, Belgium.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ImmunoPrecise

Victoria, British Columbia, Canada
Category Company
Founded 1983
Sector Life Science
Employees102
Revenue 21M CAD (2023)
DESCRIPTION

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.

DEAL STATS #
Overall 2 of 3
Sector (Internet Software and Services) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (Belgium) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-06 ModiQuest Research BV

Oss City, Netherlands

ModiQuest Research BV is an antibody solutions company focused on the next generation of technology behind therapeutic antibody discovery. ModiQuest Research is based in Oss City, Netherlands.

Buy CA$750K
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-20 Carterra s LSA Instrument

Salt Lake City, Utah, United States

Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays.

Buy -
Mergr

Product

Company

Legal